Publications
-
Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases.
Salama ME,
Lossos IS, Warnke RA, Natkunam Y.
Am J Clin Pathol.
2009;
132
(1):
39-49
-
Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP).
Gratzinger D,
Advani R, Zhao S, Talreja N, Tibshirani RJ, Shyam R, Horning S, Sehn LH, Farinha P, Briones J, Lossos IS, Gascoyne RD, Natkunam Y.
Br J Haematol.
2009
-
Extracellular signal-regulated kinase positively regulates the oncogenic activity of MCT-1 in diffuse large B-cell lymphoma.
Dai B,
Zhao XF, Hagner P, Shapiro P, Mazan-Mamczarz K, Zhao S, Natkunam Y, Gartenhaus RB.
Cancer Res.
2009;
69
(19):
7835-43
-
Microtubule-associated protein-2 is a sensitive marker of primary and metastatic neuroblastoma.
Krishnan C,
Higgins JP, West RB, Natkunam Y, Heerema-McKenney A, Arber DA.
Am J Surg Pathol.
2009;
33
(11):
1695-704
-
Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia.
Natkunam Y,
Tedoldi S, Paterson JC, Zhao S, Rodriguez-Justo M, Beck AH, Siebert R, Mason DY, Marafioti T.
Am J Clin Pathol.
2009;
132
(3):
361-71
-
Lack of utility of CD20 immunohistochemistry in staging bone marrow biopsies for diffuse large B-cell lymphoma.
Baiyee D,
Warnke R, Natkunam Y.
Appl Immunohistochem Mol Morphol.
2009;
17
(2):
93-5
-
Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens.
Fan AC,
Deb-Basu D, Orban MW, Gotlib JR, Natkunam Y, O'Neill R, Padua RA, Xu L, Taketa D, Shirer AE, Beer S, Yee AX, Voehringer DW, Felsher DW.
Nat Med.
2009;
15
(5):
566-71
-
The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities.
Gratzinger D,
Zhao S, West R, Rouse RV, Vogel H, Gil EC, Levy R, Lossos IS, Natkunam Y.
Am J Clin Pathol.
2009;
131
(2):
264-78
-
Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin.
Weinberg OK,
Ma L, Seo K, Beck AH, Pai RK, Morales A, Kim Y, Sundram U, Tan D, Horning SJ, Hoppe RT, Natkunam Y, Arber DA.
Am J Surg Pathol.
2009;
33
(4):
591-8
-
Human germinal center-associated lymphoma protein expression is associated with improved failure-free survival in Brazilian patients with classical Hodgkin lymphoma.
Azambuja D,
Lossos IS, Biasoli I, Morais JC, Britto L, Scheliga A, Pulcheri W, Natkunam Y, Spector N.
Leuk Lymphoma.
2009;
50
(11):
1830-6
-
Tissue microarrays from bone marrow aspirates for high-throughput assessment of immunohistologic markers in pediatric acute leukemia.
Hazard FK,
Zhao S, Schiffman JD, Lacayo NJ, Dahl GV, Natkunam Y.
Pediatr Dev Pathol.
2008 Jul-Aug;
11
(4):
283-90
-
The Stanford Tissue Microarray Database.
Marinelli RJ,
Montgomery K, Liu CL, Shah NH, Prapong W, Nitzberg M, Zachariah ZK, Sherlock GJ, Natkunam Y, West RB, van de Rijn M, Brown PO, Ball CA.
Nucleic Acids Res.
2008;
36
(Database issue):
D871-7
-
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.
Natkunam Y,
Farinha P, Hsi ED, Hans CP, Tibshirani R, Sehn LH, Connors JM, Gratzinger D, Rosado M, Zhao S, Pohlman B, Wongchaowart N, Bast M, Avigdor A, Schiby G, Nagler A, Byrne GE, Levy R, Gascoyne RD, Lossos IS.
J Clin Oncol.
2008;
26
(3):
447-54
-
PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling.
Lu X,
Malumbres R, Shields B, Jiang X, Sarosiek KA, Natkunam Y, Tiganis T, Lossos IS.
Blood.
2008;
112
(10):
4098-108
-
Immunohistochemical characterization of nasal-type extranodal NK/T-cell lymphoma using a tissue microarray: an analysis of 84 cases.
Schwartz EJ,
Molina-Kirsch H, Zhao S, Marinelli RJ, Warnke RA, Natkunam Y.
Am J Clin Pathol.
2008;
130
(3):
343-51
-
Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.
Malumbres R,
Chen J, Tibshirani R, Johnson NA, Sehn LH, Natkunam Y, Briones J, Advani R, Connors JM, Byrne GE, Levy R, Gascoyne RD, Lossos IS.
Blood.
2008;
111
(12):
5509-14
-
Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis.
Baecklund E,
Natkunam Y, Backlin C, Iliadou A, Askling J, Ekbom A, Feltelius N, Klareskog L, Enblad G, Lossos IS, Levy R, Sundström C, Rosenquist R.
Br J Haematol.
2008;
141
(1):
69-72
-
Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma.
Xie X,
Sundram U, Natkunam Y, Kohler S, Hoppe RT, Kim YH, Cook JR, Hammel J, Swerdlow SH, Guitart J, Smith MD, Bosler D, Listinsky C, Lossos IS, Hsi ED.
Mod Pathol.
2008;
21
(6):
653-9
-
Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy.
Gratzinger D,
Zhao S, Tibshirani RJ, Hsi ED, Hans CP, Pohlman B, Bast M, Avigdor A, Schiby G, Nagler A, Byrne GE, Lossos IS, Natkunam Y.
Lab Invest.
2008;
88
(1):
38-47
-
Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma.
Tedoldi S,
Mottok A, Ying J, Paterson JC, Cui Y, Facchetti F, van Krieken JH, Ponzoni M, Ozkal S, Masir N, Natkunam Y, Pileri S, Hansmann ML, Mason D, Tao Q, Marafioti T.
J Pathol.
2007;
213
(4):
429-40
-
Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms.
Natkunam Y,
Vainer G, Chen J, Zhao S, Marinelli RJ, Hammer AS, Hamilton-Dutoit S, Pikarsky E, Amir G, Levy R, Yisraeli JK, Lossos IS.
Haematologica.
2007;
92
(2):
176-83
-
Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes.
Gratzinger D,
Zhao S, Marinelli RJ, Kapp AV, Tibshirani RJ, Hammer AS, Hamilton-Dutoit S, Natkunam Y.
Am J Pathol.
2007;
170
(4):
1362-9
-
Mast cell tryptase and microphthalmia transcription factor effectively discriminate cutaneous mast cell disease from myeloid leukemia cutis.
Sundram UN,
Natkunam Y.
J Cutan Pathol.
2007;
34
(4):
289-95
-
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia.
Rawstron AC,
Villamor N, Ritgen M, Böttcher S, Ghia P, Zehnder JL, Lozanski G, Colomer D, Moreno C, Geuna M, Evans PA, Natkunam Y, Coutre SE, Avery ED, Rassenti LZ, Kipps TJ, Caligaris-Cappio F, Kneba M, Byrd JC, Hallek MJ, Montserrat E, Hillmen P.
Leukemia.
2007;
21
(5):
956-64
-
The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms.
Jensen KC,
Higgins JP, Montgomery K, Kaygusuz G, van de Rijn M, Natkunam Y.
Mod Pathol.
2007;
20
(8):
871-7
-
Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors.
Lehman NL,
Tibshirani R, Hsu JY, Natkunam Y, Harris BT, West RB, Masek MA, Montgomery K, van de Rijn M, Jackson PK.
Am J Pathol.
2007;
170
(5):
1793-805
-
Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival.
Natkunam Y,
Hsi ED, Aoun P, Zhao S, Elson P, Pohlman B, Naushad H, Bast M, Levy R, Lossos IS.
Blood.
2007;
109
(1):
298-305
-
The biology of the germinal center.
Natkunam Y,
Hematology Am Soc Hematol Educ Program.
2007:
210-5
-
The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas.
Natkunam Y,
Zhao S, Mason DY, Chen J, Taidi B, Jones M, Hammer AS, Hamilton Dutoit S, Lossos IS, Levy R.
Blood.
2007;
109
(4):
1636-42
-
Transmembrane adaptor molecules: a new category of lymphoid-cell markers.
Tedoldi S,
Paterson JC, Hansmann ML, Natkunam Y, Rüdiger T, Angelisova P, Du MQ, Roberton H, Roncador G, Sanchez L, Pozzobon M, Masir N, Barry R, Pileri S, Mason DY, Marafioti T, Horejsí V.
Blood.
2006;
107
(1):
213-21
-
CD10 expression in peripheral T-cell lymphomas complicated by a proliferation of large B-cells.
Reichard KK,
Schwartz EJ, Higgins JP, Narasimhan B, Warnke RA, Natkunam Y.
Mod Pathol.
2006;
19
(3):
337-43
-
Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas.
Tedoldi S,
Paterson JC, Cordell J, Tan SY, Jones M, Manek S, Dei Tos AP, Roberton H, Masir N, Natkunam Y, Pileri SA, Facchetti F, Hansmann ML, Mason DY, Marafioti T.
J Pathol.
2006;
209
(4):
454-63
-
Loss of CD19 expression in B-cell neoplasms.
Masir N,
Marafioti T, Jones M, Natkunam Y, Rüdiger T, Hansmann ML, Mason DY.
Histopathology.
2006;
48
(3):
239-46
-
Low CD27 expression in plasma cell dyscrasias correlates with high-risk disease: an immunohistochemical analysis.
Morgan TK,
Zhao S, Chang KL, Haddix TL, Domanay E, Cornbleet PJ, Arber DA, Natkunam Y.
Am J Clin Pathol.
2006;
126
(4):
545-51
-
Bringing pathobiology into focus.
Turner JR,
Maitra A, Natkunam Y, Rubin BP, Rubin MA, Teitell MA.
Lab Invest.
2006;
86
(7):
632
-
The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
Paterson JC,
Tedoldi S, Craxton A, Jones M, Hansmann ML, Collins G, Roberton H, Natkunam Y, Pileri S, Campo E, Clark EA, Mason DY, Marafioti T.
Haematologica.
2006;
91
(6):
772-80
-
Prognostic immunohistologic markers in human tumors: why are so few used in clinical practice?
Natkunam Y,
Mason DY.
Lab Invest.
2006;
86
(8):
742-7
-
EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosis.
Snow AL,
Lambert SL, Natkunam Y, Esquivel CO, Krams SM, Martinez OM.
J Immunol.
2006;
177
(5):
3283-93
-
Treatment of verruca vulgaris with topical cidofovir in an immunocompromised patient: a case report and review of the literature.
Cha S,
Johnston L, Natkunam Y, Brown J.
Transpl Infect Dis.
2005 Sep-Dec;
7
(3-4):
158-61
-
Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage.
Nguyen TT,
Schwartz EJ, West RB, Warnke RA, Arber DA, Natkunam Y.
Am J Surg Pathol.
2005;
29
(5):
617-24
-
Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma.
Marafioti T,
Pozzobon M, Hansmann ML, Gaulard P, Barth TF, Copie-Bergman C, Roberton H, Ventura R, Martín-Subero JI, Gascoyne RD, Pileri SA, Siebert R, Hsi ED, Natkunam Y, Möller P, Mason DY.
Leukemia.
2005;
19
(5):
856-61
-
A novel method for making "tissue" microarrays from small numbers of suspension cells.
Montgomery K,
Zhao S, van de Rijn M, Natkunam Y.
Appl Immunohistochem Mol Morphol.
2005;
13
(1):
80-4
-
Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study.
Sundram U,
Kim Y, Mraz-Gernhard S, Hoppe R, Natkunam Y, Kohler S.
J Cutan Pathol.
2005;
32
(3):
227-34
-
Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation.
Natkunam Y,
Lossos IS, Taidi B, Zhao S, Lu X, Ding F, Hammer AS, Marafioti T, Byrne GE, Levy S, Warnke RA, Levy R.
Blood.
2005;
105
(10):
3979-86
-
The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas.
Marafioti T,
Marafiot T, Pozzobon M, Hansmann ML, Ventura R, Pileri SA, Roberton H, Gesk S, Gaulard P, Barth TF, Du MQ, Leoncini L, Möller P, Natkunam Y, Siebert R, Mason DY.
Br J Haematol.
2005;
128
(3):
333-42
-
Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells.
Verneris MR,
Arshi A, Edinger M, Kornacker M, Natkunam Y, Karami M, Cao YA, Marina N, Contag CH, Negrin RS.
Clin Cancer Res.
2005;
11
(12):
4561-70
-
Cytologic diagnosis of Burkitt lymphoma.
Troxell ML,
Bangs CD, Cherry AM, Natkunam Y, Kong CS.
Cancer.
2005;
105
(5):
310-8
-
TMA-Combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays.
Liu CL,
Montgomery KD, Natkunam Y, West RB, Nielsen TO, Cheang MC, Turbin DA, Marinelli RJ, van de Rijn M, Higgins JP.
Mod Pathol.
2005;
18
(12):
1641-8
-
Utility of syndecan-1 (CD138) expression in the diagnosis of undifferentiated malignant neoplasms: a tissue microarray study of 1,754 cases.
Kambham N,
Kong C, Longacre TA, Natkunam Y.
Appl Immunohistochem Mol Morphol.
2005;
13
(4):
304-10
-
Follicular dendritic cell immunohistochemical markers in angioimmunoblastic T-cell lymphoma.
Troxell ML,
Schwartz EJ, van de Rijn M, Ross DT, Warnke RA, Higgins JP, Natkunam Y.
Appl Immunohistochem Mol Morphol.
2005;
13
(4):
297-303
-
Atypical cellular disorders.
McClain KL,
Natkunam Y, Swerdlow SH.
Hematology Am Soc Hematol Educ Program.
2004:
283-96
-
Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples.
Pozzobon M,
Marafioti T, Hansmann ML, Natkunam Y, Mason DY.
Br J Haematol.
2004;
124
(4):
519-33
-
Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells.
Masir N,
Jones M, Pozzobon M, Marafioti T, Volkova OY, Mechetina LV, Hansmann ML, Natkunam Y, Taranin AV, Mason DY.
Br J Haematol.
2004;
127
(3):
335-43
-
Immunophenotypic and genotypic characterization of progression in follicular lymphomas.
Natkunam Y,
Soslow R, Matolcsy A, Dolezal M, Bhargava V, Knowles DM, Warnke R.
Appl Immunohistochem Mol Morphol.
2004;
12
(2):
97-104
-
Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA.
Sundram U,
Harvell JD, Rouse RV, Natkunam Y.
Mod Pathol.
2003;
16
(8):
802-10
-
Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report.
Nguyen DD,
Loo BW, Tillman G, Natkunam Y, Cao TM, Vaughan W, Dorfman RF, Goffinet DR, Jacobs CD, Advani RH.
Ann Hematol.
2003;
82
(8):
521-5
-
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial.
Ekstrand BC,
Lucas JB, Horwitz SM, Fan Z, Breslin S, Hoppe RT, Natkunam Y, Bartlett NL, Horning SJ.
Blood.
2003;
101
(11):
4285-9
-
Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas.
Nepomuceno RR,
Balatoni CE, Natkunam Y, Snow AL, Krams SM, Martinez OM.
Cancer Res.
2003;
63
(15):
4472-80
-
Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.
Fan Z,
Natkunam Y, Bair E, Tibshirani R, Warnke RA.
Am J Surg Pathol.
2003;
27
(10):
1346-56
-
The usefulness of immunohistochemistry in the diagnosis of follicular lymphoma in bone marrow biopsy specimens.
West RB,
Warnke RA, Natkunam Y.
Am J Clin Pathol.
2002;
117
(4):
636-43
-
Epstein-Barr virus infection is associated with endothelial Bcl-2 expression in transplant liver allografts.
Millan MT,
Natkunam Y, Clarke-Katzenberg R, Desai D, Prapong W, So SK, Esquivel CO, Sibley R, Ferran C, Martinez OM.
Transplantation.
2002;
73
(3):
465-9
-
Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: correlation with clinical outcome.
Lossos IS,
Natkunam Y, Levy R, Lopez CD.
Leuk Lymphoma.
2002;
43
(12):
2309-17
-
Large atypical cells of lymphomatoid papulosis are CD56-negative: a study of 18 cases.
Harvell J,
Vaseghi M, Natkunam Y, Kohler S, Kim Y.
J Cutan Pathol.
2002;
29
(2):
88-92
-
Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays.
Liu CL,
Prapong W, Natkunam Y, Alizadeh A, Montgomery K, Gilks CB, van de Rijn M.
Am J Pathol.
2002;
161
(5):
1557-65
-
Natural killer cell precursor acute lymphoma/leukemia presenting in an infant.
Natkunam Y,
Cherry AM, Cornbleet PJ.
Arch Pathol Lab Med.
2001;
125
(3):
413-8
-
Angiocentric lymphomas (lymphomatous vasculitis).
Natkunam Y,
Warnke RA.
Semin Diagn Pathol.
2001;
18
(1):
67-77
-
Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course.
Mraz-Gernhard S,
Natkunam Y, Hoppe RT, LeBoit P, Kohler S, Kim YH.
J Clin Oncol.
2001;
19
(8):
2179-88
-
Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.
Lossos IS,
Jones CD, Warnke R, Natkunam Y, Kaizer H, Zehnder JL, Tibshirani R, Levy R.
Blood.
2001;
98
(4):
945-51
-
A unique AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a patient with acute myelomonocytic leukemia.
Cherry AM,
Bangs CD, Jones P, Hall S, Natkunam Y.
Cancer Genet Cytogenet.
2001;
129
(2):
155-60
-
Durable remission in recurrent T-cell-rich B-cell lymphoma with the anti-CD20 antibody rituximab.
Natkunam Y,
Stanton TS, Warnke RA, Horning SJ.
Clin Lymphoma.
2001;
2
(3):
185-7
-
Modified cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone therapy for posttransplantation lymphoproliferative disease in pediatric patients undergoing solid organ transplantation.
Suryanarayan K,
Natkunam Y, Berry G, Bangs CD, Cherry A, Dahl G.
J Pediatr Hematol Oncol.
2001;
23
(7):
452-5
-
Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry.
Natkunam Y,
Warnke RA, Montgomery K, Falini B, van De Rijn M.
Mod Pathol.
2001;
14
(7):
686-94
-
Immunoblot analysis of CD34 expression in histologically diverse neoplasms.
Natkunam Y,
Rouse RV, Zhu S, Fisher C, van De Rijn M.
Am J Pathol.
2000;
156
(1):
21-7
-
Blastic/blastoid transformation of follicular lymphoma: immunohistologic and molecular analyses of five cases.
Natkunam Y,
Warnke RA, Zehnder JL, Jones CD, Milatovich-Cherry A, Cornbleet PJ.
Am J Surg Pathol.
2000;
24
(4):
525-34
-
Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases.
Natkunam Y,
Warnke RA, Haghighi B, Su LD, Le Boit PE, Kim YH, Kohler S.
J Cutan Pathol.
2000;
27
(8):
392-9
-
Utility of paraffin section immunohistochemistry for C-KIT (CD117) in the differential diagnosis of systemic mast cell disease involving the bone marrow.
Natkunam Y,
Rouse RV.
Am J Surg Pathol.
2000;
24
(1):
81-91
-
Aggressive natural killer-like T-cell malignancy with leukemic presentation following solid organ transplantation.
Natkunam Y,
Warnke RA, Zehnder JL, Cornbleet PJ.
Am J Clin Pathol.
1999;
111
(5):
663-71
-
Aggressive cutaneous NK and NK-like T-cell lymphomas: clinicopathologic, immunohistochemical, and molecular analyses of 12 cases.
Natkunam Y,
Smoller BR, Zehnder JL, Dorfman RF, Warnke RA.
Am J Surg Pathol.
1999;
23
(5):
571-81
-
Epstein-Barr virus strain type and latent membrane protein 1 gene deletions in lymphomas in patients with rheumatic diseases.
Natkunam Y,
Elenitoba-Johnson KS, Kingma DW, Kamel OW.
Arthritis Rheum.
1997;
40
(6):
1152-6
-
Simultaneous activation of Ig and Oct-2 synthesis and reduction of surface MHC class II expression by IL-6.
Natkunam Y,
Zhang X, Liu Z, Chen-Kiang S.
J Immunol.
1994;
153
(8):
3476-84
-
Nuclear signaling by interleukin-6.
Chen-Kiang S,
Hsu W, Natkunam Y, Zhang X.
Curr Opin Immunol.
1993;
5
(1):
124-8
Help